Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Press Release

Document Details

Form
3
Filing Date
Jun 20, 2018
Document Date
Jun 20, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
BONNEY MICHAEL W

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS